Notes on a clinical conference on insulin

Collection

Identifier: MS C 450

Abstract

Dates

1922

Extent

0.21 Linear Feet (1 box)

Physical Location

Materials stored onsite. History of Medicine Division. National Library of Medicine

Language of Materials

Collection materials primarily in English

Restrictions

Collection is not restricted. Contact the Reference Staff for information regarding access.

Copyright and Re-use Information

NLM does not possess copyright to the collection. Archival collections often contain mixed copyrights; while NLM is the owner of the physical items, permission to examine collection materials is not an authorization to publish. These materials are made available for use in research, teaching, and private study. It is the user's responsibility to research and understand any applicable copyright and re-publication rights not allowed by fair use. NLM does not grant permissions to publish.

Privacy Information

Archives and manuscript collections may contain materials with sensitive or confidential information that is protected under federal or state right to privacy laws and regulations. Researchers are advised that the disclosure of certain information pertaining to identifiable living individuals represented in any collection without the consent of those individuals may have legal ramifications for which the National Library of Medicine assumes no responsibility.

Biographical Note

Born in Cincinnati, Russell M. Wilder received a Ph.D. from the University of Chicago and an M.D. from Rush Medical College, both in 1912. Because of his expertise in metabolic diseases, Wilder was one of a select few invited to the 1922 conference at the University of Toronto. From 1919 until his death, he was worked primarily for the Mayo Clinic. He was director of the National Institute of Diabetes and Digestive and Kidney Diseases, 1951-1953.

Collection Summary

Wilder's holographic notes on an invitational conference held at the University of Toronto on Nov. 25-26, 1922, to discuss the clinical applications of insulin (which had just been isolated) and to determine how best to produce and distribute it. Includes a list of participants, notes on the discussion, a draft of a letter in support, and presentation and discussion of various cases treated with insulin.